Jupiter Asset Management LTD Fibrogen Inc Transaction History

Jupiter Asset Management LTD

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$31.0 - $55.72 $3.19 Million - $5.74 Million
-103,026 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$37.09 - $48.97 $2.49 Million - $3.29 Million
67,112 Added 186.87%
103,026 $3.83 Million
Q3 2020

Nov 10, 2020
BUY
$40.47 - $45.5 $1.45 Million - $1.63 Million
35,914 New
35,914 $1.48 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email